Lightning Round: Jim Cramer Weighs In On Juno Therapeutics, Halliburton And More
August 18, 2017 at 07:54 AM EDT
On CNBC's "Mad Money Lightning Round", Jim Cramer said Juno Therapeutics Inc(NASDAQ: JUNO) is a high risk immunotherapy ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|